Molecular Epidemiology and Antimicrobial Resistance Laboratory, Division of Epidemiology, Tel Aviv Medical Centre, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
J Hosp Infect. 2012 May;81(1):15-9. doi: 10.1016/j.jhin.2012.02.007. Epub 2012 Mar 30.
Over the last decade, extremely-drug-resistant (XDR) strains of Klebsiella pneumoniae have emerged worldwide, mainly as a result of patient-to-patient spread. The predominant clone, sequence type 258 (ST258), is associated with high morbidity and mortality, and is a worldwide threat to public health. It was hypothesized that reduced susceptibility to chlorhexidine, the most widely used hospital disinfectant, may contribute to the endemic nature of this strain.
To characterize and compare the susceptibility of the epidemic K. pneumoniae clone ST258 and non-epidemic K. pneumoniae clones to chlorhexidine.
The minimum inhibitory concentration (MIC) of chlorhexidine was determined in 126 XDR K. pneumoniae clinical isolates using agar dilution. Expression of three different efflux pumps -cepA, acrA and kdeA - was investigated in the absence and presence of chlorhexidine using quantitative real-time polymerase chain reaction. Heteroresistance to chlorhexidine was identified using population analysis.
The MIC of chlorhexidine was higher for K. pneumoniae ST258 (N = 70) than other K. pneumoniae sequence types (N = 56); 99% of ST258 isolates had MICs >32 μg/mL, compared with 52% of other K. pneumoniae sequence types (P < 0.0001). Reduced susceptibility to chlorhexidine appeared to be independent of the expression of cepA, acrA and kdeA efflux pumps. Chlorhexidine-resistant subpopulations were observed independent of the bacterial sequence type or the MIC.
Reduced susceptibility to chlorhexidine may contribute to the success of XDR K. pneumoniae as a nosocomial pathogen, and may provide a selective advantage to the international epidemic strain K. pneumoniae ST258. The heterogeneous nature of chlorhexidine-resistant subpopulations suggests that this phenomenon might not be rendered genetically.
在过去十年中,世界范围内出现了耐多药(XDR)肺炎克雷伯菌,主要是由于患者之间的传播。主要克隆株,序列类型 258(ST258),与高发病率和死亡率相关,是对全球公共卫生的威胁。据推测,对最广泛使用的医院消毒剂洗必泰的敏感性降低可能导致该菌株的地方性。
描述并比较流行的肺炎克雷伯菌克隆株 ST258 和非流行肺炎克雷伯菌克隆株对洗必泰的敏感性。
使用琼脂稀释法测定 126 株 XDR 肺炎克雷伯菌临床分离株对洗必泰的最小抑菌浓度(MIC)。使用定量实时聚合酶链反应在有无洗必泰的情况下研究三种不同的外排泵-cepa、acra 和 kdea 的表达。使用群体分析鉴定对洗必泰的异质性耐药。
肺炎克雷伯菌 ST258(N=70)对洗必泰的 MIC 高于其他肺炎克雷伯菌序列类型(N=56);99%的 ST258 分离株 MIC 值>32μg/ml,而其他肺炎克雷伯菌序列类型的 52%(P<0.0001)。对洗必泰的低敏感性似乎与 cepA、acra 和 kdeA 外排泵的表达无关。无论细菌序列类型或 MIC 如何,都观察到对洗必泰耐药的亚群。
对洗必泰的低敏感性可能有助于 XDR 肺炎克雷伯菌成为医院病原体的成功,并可能为国际流行株肺炎克雷伯菌 ST258 提供选择性优势。洗必泰耐药亚群的异质性表明,这种现象可能不是遗传的。